Table: Sumitomo Pharma -2022/23 group forecast(IFRS)

Sumitomo Pharma

31/10/2022 06:30

Oct 31 (Reuters) -
              Sumitomo Pharma Co., Ltd.     
              CONSOLIDATED EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2023      Mar 31, 2023   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales           604.00            550.00      
  Operating     loss 30.00           24.00      
  Net           loss 15.00           22.00      
  EPS Basic   loss 37.76 yen       55.37 yen    
 
  NOTE - Sumitomo Pharma Co., Ltd..(Figures are reported based on international accounting rules (IFRS).)    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4506.T